James C. Momtazee

Filings by James C. Momtazee span 3 companies, the busiest being Roivant Sciences Ltd., BridgeBio Pharma, Inc. and PRA Health Sciences, Inc. In total, 31 filings cover trades dated from 1 June 2021 to 16 September 2026.

Purchases make up the whole of the open-market record (1 purchase, €1.0M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 27 share grants.

Most recently, on 18 September 2026, the filings show a share grant in Roivant Sciences Ltd. The clock since the last published purchase (3 January 2022) now reads 1,749 days. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.